Search Results - "Wallman, J K"

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control? by Roseman, C, Wallman, J K, Jöud, A, Schelin, Mec, Einarsson, J T, Lindqvist, E, Lampa, J, Kapetanovic, M C, Olofsson, T

“…While considerable focus has been placed on pain due to inflammation in psoriatic arthritis (PsA), less is reported on pain despite inflammation control. Here,…”
Get full text

Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy: results from the ICEBIO registry by Palsson, O, Love, T J, Wallman, J K, Kapetanovic, M C, Gunnarsson, P S, Gudbjornsson, B

“…To study the impact of tumour necrosis factor-α inhibitor (TNFi) therapy on the use of non-steroidal anti inflammatory drugs (NSAIDs) in patients with…”
Get full text

Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population by Hambardzumyan, K, Hermanrud, C, Marits, P, Vivar, N, Ernestam, S, Wallman, JK, van Vollenhoven, RF, Fogdell-Hahn, A, Saevarsdottir, S

“…Objective: Infliximab-treated patients with rheumatoid arthritis (RA) may respond insufficiently due to low serum infliximab (sIFX) levels, caused by anti-drug…”
Get full text

Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register by Wallman, JK, Alenius, G-M, Klingberg, E, Sigurdardottir, V, Wedrén, S, Exarchou, S, Lindström, U, Di Giuseppe, D, Askling, J, Jacobsson, LTH

“…: Knowledge of the correspondence between clinical ICD diagnoses and classification criteria fulfilment is crucial to interpret studies identifying cases via…”
Get full text

What PASSes for good? Experience-based Swedish and hypothetical British EuroQol 5-Dimensions preference sets yield markedly different point estimates and patient acceptable symptom state cut-off values in chronic arthritis patients on TNF blockade by Cooper, A, Wallman, JK, Gülfe, A

“…Objectives: Health utilities derived from answers to generic health-related quality of life (HRQoL) questionnaires such as the EuroQol 5-Dimensions (EQ-5D) are…”
Get full text

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries by Glintborg, Bente, Di Giuseppe, Daniela, Wallman, Johan Karlsson, Nordström, Dan C, Gudbjornsson, Bjorn, Hetland, Merete Lund, Askling, Johan, Grondal, Gerdur, Sokka, Tuulikki, Provan, Sella A, Michelsen, Brigitte, Kristianslund, Eirik Klami, Dreyer, Lene, Love, Thorvardur Jon, Lindström, Ulf

“…We aimed to describe the uptake of newer biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in psoriatic arthritis (PsA) in the…”
Get more information

The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017 by Exarchou, Sofia, Wallman, Johan K, Di Giuseppe, Daniela, Klingberg, Eva, Sigurdardottir, Valgerdur, Wedrén, Sara, Lindström, Ulf, Turesson, Carl, Jacobsson, Lennart T H, Askling, Johan

“…Psoriatic arthritis (PsA) prevalence estimates vary across studies; studies based on national data are few. We aimed to estimate the prevalence of clinically…”
Get full text

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries by Glintborg, Bente, Di Giuseppe, Daniela, Wallman, Johan K, Provan, Sella A, Nordström, Dan, Hokkanen, Anna-Mari, Österlund, Jenny, Kristianslund, Eirik, Kvien, Tore K, Gudbjornsson, Bjorn, Hetland, Merete Lund, Michelsen, Brigitte, Jacobsson, Lennart, Askling, Johan, Lindström, Ulf

“…The positioning of secukinumab in the treatment of axial SpA (axSpA) and PsA is debated, partly due to a limited understanding of the comparative safety of the…”
Get full text

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis by Lindström, Ulf, Glintborg, Bente, Di Giuseppe, Daniela, Schjødt Jørgensen, Tanja, Gudbjornsson, Bjorn, Lederballe Grøn, Kathrine, Aarrestad Provan, Sella, Michelsen, Brigitte, Lund Hetland, Merete, Wallman, Johan K, Nordström, Dan, Trokovic, Nina, Love, Thorvardur Jon, Krogh, Niels Steen, Askling, Johan, Jacobsson, Lennart T H, Kristensen, Lars Erik

“…To compare treatment retention and response to secukinumab vs adalimumab, including the other four TNF inhibitors (TNFi) as comparators, in PsA. All patients…”
Get full text

Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study by Lund Hansen, Rebekka, Schoedt Jørgensen, Tanja, Dreyer, Lene, Hetland, Merete L, Glintborg, Bente, Askling, Johan, Di Giuseppe, Daniela, Jacobsson, Lennart T H, Wallman, Johan K, Nordstrom, Dan, Aaltonen, Kalle, Kristianslund, Eirik K, Kvien, Tore K, Provan, Sella A, Gudbjornsson, Bjorn, Love, Thorvadur J, Kristensen, L E

“…Abstract Objectives To assess secular trends in baseline characteristics of PsA patients initiating their first or subsequent biologic DMARD (bDMARD) therapy…”
Get full text

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study by Lindström, Ulf, di Giuseppe, Daniela, Exarchou, Sofia, Alenius, Gerd-Marie, Olofsson, Tor, Klingberg, Eva, Jacobsson, Lennart, Askling, Johan, Wallman, Johan K

“…IntroductionWe aimed to compare the proportions of patients with newly diagnosed psoriatic arthritis (PsA) and rheumatoid arthritis (RA) remaining on…”
Get full text

Subclinical brain swelling in children during treatment of diabetic ketoacidosis by Krane, E J, Rockoff, M A, Wallman, J K, Wolfsdorf, J I

“…Clinically apparent cerebral edema is a rare and often fatal complication of diabetic ketoacidosis. To determine whether subclinical brain swelling occurs more…”
Get more information

Cranial CT of autosomal recessive osteopetrosis by Bartynski, WS, Barnes, PD, Wallman, JK

“…Eight infants with radiographic and bone biopsy evidence of autosomal recessive osteopetrosis were evaluated by cranial CT. The clinical presentations and CT…”
Get full text

Proton magnetic resonance studies of triethyltin-induced edema during perinatal brain development in rabbits by Lorenzo, A V, Jolesz, F A, Wallman, J K, Ruenzel, P W

“…To better understand the role of myelin-associated water in the differentiation of white and gray matter in magnetic resonance (MR) imaging, changes in MR…”
Get more information

Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort by Mogard, Elisabeth, Olofsson, Tor, Bergman, Stefan, Bremander, Ann, Kristensen, Lars Erik, Olsen, Jack Kvistgaard, Wallman, Johan K., Lindqvist, Elisabet

“…Objective To study differences in pain reports between patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (nr-axSpA), and to…”
Get full text

Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis by Sagard, Jonas, Olofsson, Tor, Mogard, Elisabeth, Marsal, Jan, Andréasson, Kristofer, Geijer, Mats, Kristensen, Lars Erik, Lindqvist, Elisabet, Wallman, Johan K

“…Based on clinical and genetic associations, axial spondyloarthritis (axSpA) and inflammatory bowel disease (IBD) are suspected to have a linked pathogenesis…”
Get full text

How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort by Lindqvist, Elisabet, Olofsson, Tor, Jöud, Anna, Geijer, Mats, Wallman, Johan K, Mogard, Elisabeth

“…To study the agreement between clinical axial spondyloarthritis (axSpA) diagnoses and fulfilment of the Assessment of SpondyloArthritis international Society…”
Get full text

Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity? by Wallman, Johan Karlsson, Mogard, Elisabeth, Marsal, Jan, Andréasson, Kristofer, Jöud, Anna, Geijer, Mats, Kristensen, Lars Erik, Lindqvist, Elisabet, Olofsson, Tor

Get more information

One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses by Glintborg, Bente, Lindström, Ulf, Giuseppe, Daniela Di, Provan, Sella Aarrestad, Gudbjornsson, Bjorn, Hetland, Merete Lund, Michelsen, Brigitte, Wallman, Johan K., Aaltonen, Kalle, Hokkanen, Anna‐Mari, Nordström, Dan, Jørgensen, Tanja Schjødt, Hansen, Rebekka Lund, Geirsson, Arni Jon, Grøn, Kathrine Lederballe, Krogh, Niels Steen, Askling, Johan, Kristensen, Lars Erik, Jacobsson, Lennart T. H.

“…Objective To describe baseline characteristics and to compare treatment effectiveness of secukinumab versus tumor necrosis factor inhibitors (TNFi) in patients…”
Get full text

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries by Linde, Louise, Ørnbjerg, Lykke M, Georgiadis, Stylianos, H Rasmussen, Simon, Lindström, Ulf, Askling, Johan, Michelsen, Brigitte, Di Giuseppe, Daniela, Wallman, Johan K, Gudbjornsson, Bjorn, Love, Thorvardur Jon, Nordström, Dan C, Yli-Kerttula, Timo, Nekvindová, Lucie, Vencovský, Jiří, Iannone, Florenzo, Cauli, Alberto, Loft, Anne Gitte, Glintborg, Bente, Laas, Karin, Rotar, Ziga, Tomšič, Matija, Macfarlane, Gary J, Möller, Burkhard, van de Sande, Marleen, Codreanu, Catalin, Nissen, Michael J, Birlik, Merih, Erten, Sukran, Santos, Maria J, Vieira-Sousa, Elsa, Hetland, Merete L, Østergaard, Mikkel

“…In bio-naïve patients with PsA initiating a TNF inhibitor (TNFi), we aimed to identify baseline predictors of Disease Activity index for PsA in 28 joints…”
Get full text